Title: Rivaroxaban for the prevention of venous thromboembolism
Source: NICE
The Skinny: This guidance is about when rivaroxaban should be used to reduce the risk of thromboembolism in adults who have surgery to replace their hip or knee joints in the NHS in England and Wales. It explains guidance (advice) from NICE (the National Institute for Health and Clinical Excellence). It does not cover using rivaroxaban to reduce the risk of venous thromboembolism in adults who have had other types of surgery.
Documents For healthcare professionals:
- TA170 Venous thromboembolism – rivaroxaban: guidance (23p, 190.93 Kb)
- TA170 Venous thromboembolism – rivaroxaban: guidance (MS Word format) (23p, 553.5 Kb)
- TA170 Venous thromboembolism – rivaroxaban: quick ref guide(2p, 42.73 Kb)
Documents For patients, carers and the public:
- TA170 Venous thromboembolism – rivaroxaban: understanding NICE guidance (4p, 72.27 Kb)
- TA170 Venous thromboembolism – rivaroxaban: understanding NICE guidance (MS Word format) (4p, 553.5 Kb)
Implementing the guidance:
- Venous thromboembolism – rivaroxaban: costing statement (3p, 34.59 Kb)
- Venous thromboembolism – rivaroxaban: audit support (4p, 163 Kb)
Date of publication: April 2009
Publication type: Technology Appraisal
Acknowledgement: http://www.nice.org.uk
